As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer retail industry, ...

Consumer M&A roared into 2025 with a sharp rebound in mega-deals, a surge in private equity activity, and a clear tilt toward ...

Venmo aims to be more than just an app for paying friends with its latest update. On Wednesday, the PayPal-owned payment ...

As the dust settles on the purchase, Sycamore has indicated an interest in splitting Walgreens into three business units: one focused on U.S. pharmacies, one on U.K. pharmacies and one on U.S. primary ...

Walgreens reported Q1 sales of $39.46 billion ... largely driven by weaker retail front-end performance. Earlier this year, the U.S. Department of Justice filed a civil complaint against ...

Walgreens stock surged 27% on Friday, Jan 10, after the company reported upbeat Q1 (fiscal ends in August) results. It reported revenue of $39.5 billion and adjusted earnings of $0.51 per share ...

The improved performance of VillageMD and Shields allowed Walgreens to bring its operating loss in the U.S. healthcare segment down to $325 million in the first quarter, compared to $436 million ...

Shares of Walgreens Boots Alliance ($WBA) have risen nearly 24% in the past five days as the pharmacy retailer gets price target revisions following its strong first ...

Walgreens Boots Alliance Inc. ( (WBA)) has released its Q1 earnings. Here is a breakdown ... a robust 10.2% sales growth, boosted by performance in Boots UK and Germany. Looking ahead, Walgreens ...

comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Walgreens performed in the just reported ...

Walgreens reported Q1 sales of $39.5 billion ... in U.S. Retail Pharmacy largely driven by weaker retail front end performance. Price Action: WBA stock is up 16.3% at $10.72 during the premarket ...